AVITA Medical, Inc. (RCEL)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, AVITA Medical, Inc. reported revenue of $71.61M, up 11.5% from the prior year. The company ran a net loss, with a net margin of -67.8% and a gross margin of 82.1%. It held $56.39M in total assets against $73.04M in total liabilities.
Key ratios (FY2025)
82.1%
Gross margin
-59.4%
Operating margin
-67.8%
Net margin
+11.5%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.61M | $64.25M | $50.14M | $34.42M | $29.23M | $14.26M | $5.47M | $929.0K | — |
| Cost of Revenue | $12.79M | $9.09M | $7.78M | $6.04M | $5.95M | $2.97M | $1.27M | $546.0K | — |
| Gross Profit | $58.82M | $55.16M | $42.36M | $28.38M | $23.28M | $11.29M | $4.20M | $383.0K | — |
| Operating Income | -$42.53M | -$56.59M | -$42.66M | -$27.50M | -$26.54M | -$42.68M | -$25.53M | -$13.84M | — |
| Net Income | -$48.59M | -$61.84M | -$35.38M | -$26.66M | -$26.58M | -$42.03M | -$25.10M | -$12.73M | — |
| EPS (Diluted) | $-1.74 | $-2.39 | $-1.40 | $1.07 | $1.17 | $2.07 | $1.56 | $1.37 | — |
| Total Assets | $56.39M | $79.71M | $111.64M | $98.26M | $116.02M | $82.46M | $25.78M | — | — |
| Total Liabilities | $73.04M | $74.97M | $61.89M | $12.97M | $11.39M | $10.06M | $4.95M | — | — |
| Shareholders' Equity | -$16.65M | $4.50M | $49.06M | $84.74M | $104.62M | $72.40M | $20.83M | $14.03M | $3.93M |
| Cash & Equivalents | $10.24M | $14.05M | $22.12M | $18.16M | $55.51M | $73.64M | $20.17M | — | — |
| Operating Cash Flow | -$31.20M | -$48.94M | -$38.01M | -$19.09M | -$25.90M | -$22.75M | -$19.25M | -$12.96M | — |
| Capital Expenditures | $1.00M | $9.17M | $1.38M | $452.0K | $894.0K | $590.0K | $1.02M | $365.0K | — |
| Shares Outstanding | 27.86M | 25.88M | 25.33M | 25.00M | 22.67M | 20.29M | 16.06M | 9.33M | — |